אינג'י 10 מג80 מג טבליות

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

EZETIMIBE; SIMVASTATIN

から入手可能:

MERCK SHARP & DOHME ISRAEL LTD

ATCコード:

C10AA01

医薬品形態:

טבליה

構図:

EZETIMIBE 10 MG; SIMVASTATIN 80 MG

投与経路:

פומי

処方タイプ:

מרשם נדרש

製:

MERCK SHARP & DOHME (ITALIA) S.P.A.

治療群:

SIMVASTATIN

治療領域:

SIMVASTATIN

適応症:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

承認日:

2012-04-30